Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Estrogen replacement therapy: for whom, why and how?].

S Rozenberg1, S Neusy, J Barudy

  • 1Service de Gynécologie-Obstétrique, C.H.U. Saint-Pierre, U.L.B.

Revue Medicale De Bruxelles
|November 9, 2002
PubMed
Summary

Hormone replacement therapy (HRT) and Selective Estrogen Receptor Modulators (SERMs) offer benefits for bone density and potentially cardiovascular health during perimenopause. However, risks regarding cardiovascular events and thrombosis require careful consideration.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Menopausal hormone therapy and ovarian cancer: Risk assessment of various regimens and risk evaluation in ovarian cancer survivors.

Maturitas·2026
Same author

Menopausal hormone therapy and endometrial cancer: Risk assessment of various regimens and risk evaluation for endometrial cancer survivors.

Maturitas·2026
Same author

Randomized trial: treatment of genitourinary syndrome of menopause using radiofrequency.

Climacteric : the journal of the International Menopause Society·2024
Same author

MOF/Hip Fracture Ratio in a Belgian Cohort of Post-menopausal Women (FRISBEE): Potential Impact on the FRAX® Score.

Calcified tissue international·2021
Same author

Discriminating value of HR-pQCT for fractures in women with similar FRAX scores: A substudy of the FRISBEE cohort.

Bone·2020
Same author

The Belgian Bone Club 2020 guidelines for the management of osteoporosis in postmenopausal women.

Maturitas·2020

Area of Science:

  • Reproductive Endocrinology
  • Pharmacology
  • Gerontology

Context:

  • Perimenopausal symptoms can be challenging to manage.
  • Low-dose hormone replacement therapy (HRT) and oral contraceptives are common treatments.
  • HRT aids bone density maintenance, even in elderly women.

Purpose:

  • To review the efficacy and risks of HRT and SERMs in perimenopausal women.
  • To evaluate HRT's impact on bone health, cardiovascular pathologies, and breast cancer.
  • To discuss the controversial findings regarding HRT and cardiovascular events.

Summary:

  • Progestins manage abnormal bleeding; low-dose HRT improves compliance and preserves bone mass, though fracture protection data is limited.
  • HRT's cardiovascular effects are debated: observational studies suggest protection, but randomized trials indicate increased cardiovascular events.

Related Experiment Videos

  • Selective Estrogen Receptor Modulators (SERMs) offer bone and potential cardiovascular benefits but carry similar thrombosis risks to estrogens.

    • Impact:

    • Improved understanding of HRT and SERM risks and benefits for perimenopausal women.
    • Highlights the need for further research into fracture protection and long-term cardiovascular outcomes.
    • Informs clinical decision-making regarding menopausal symptom management and associated health risks.